Table: Wakamoto Pharm - Q1 parent results

Wakamoto Pharmaceutical

04/08/2022 07:00

Aug 4 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             2.02                1.97             8.50     
                 (+2.9 pct)                           (+1.4 pct)  
  Operating      loss 24 mln         loss 47 mln        90 mln    
  Recurring      loss 2 mln          loss 23 mln        110 mln   
                                                      (+52.2 pct) 
  Net            loss 4 mln            44 mln           150 mln   
                                     (+32.6 pct)      (-37.1 pct) 
  EPS           loss 0.14 yen         1.29 yen         4.32 yen   
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T